Trends in upper gastro-intestinal cancer among the elderly in Denmark, 1980–2012

References

• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69–90.
   PubMed Web of Science ®Google Scholar
• Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74–108.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013;49:1374–403.
   PubMed Web of Science ®Google Scholar
• Christensen K, Doblhammer G, Rau R, Vaupel JW. Ageing populations: the challenges ahead. Lancet 2009;374:1196–208.
   PubMed Web of Science ®Google Scholar
• Bernardi D, Errante D, Tirelli U, Salvagno L, Bianco A, Fentiman IS. Insight into the treatment of cancer in older patients: developments in the last decade. Cancer Treat Rev 2006;32:277–88.
   PubMed Web of Science ®Google Scholar
• Monfardini S. Geriatric oncology: a new subspecialty? J Clin Oncol 2004;22:4655
   PubMed Web of Science ®Google Scholar
• Shitara K, Ikeda J, Kondo C, Takahari D, Ura T, Muro K, et al. Reporting patient characteristics and stratification factors in randomized trials of systemic chemotherapy for advanced gastric cancer. Gastric Cancer 2012;15:137–43.
   PubMed Web of Science ®Google Scholar
• Ewertz M, Christensen K, Engholm G, Kejs AMT, Lund L, Matzen LE, et al. Trends in cancer in elderly population in Denmark, 1980-2012. Acta Oncol 2015; doi: 10.3109/0284186X.2015.1114678.
   Web of Science ®Google Scholar
• Dickman PW, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Stat Med 2004;23:51–64.
   PubMed Web of Science ®Google Scholar
• Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet 2013;381:400–12.
   PubMed Web of Science ®Google Scholar
• Bosetti C, Bertuccio P, Malvezzi M, Levi F, Chatenoud L, Negri E, et al. Cancer mortality in Europe, 2005-2009, and an overview of trends since 1980. Ann Oncol 2013;24:2657–71.
   PubMed Web of Science ®Google Scholar
• Fock KM. Review article: the epidemiology and prevention of gastric cancer. Aliment Pharmacol Ther 2014;40:250–60.
   PubMed Web of Science ®Google Scholar
• Gavin AT, Francisci S, Foschi R, Donnelly DW, Lemmens V, Brenner H, et al. Oesophageal cancer survival in Europe: A EUROCARE-4 study. Cancer Epidemiology 2012;36:505–12.
   PubMed Web of Science ®Google Scholar
• Schønnemann KR, Mortensen MB, Bjerregaard JK, Fristrup C, Pfeiffer P. Characteristics, therapy and outcome in an unselected and prospectively registered cohort of patients with gastro-oesophageal cancer. Acta Oncol 2014;53:385–91.
   PubMed Web of Science ®Google Scholar
• Lauren P. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification.. Acta Pathol Microbiol Scand 1965;64:31–49.
   PubMedGoogle Scholar
• Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 2009;45:931–91.
   PubMed Web of Science ®Google Scholar
• Wani S, Das A, Rastogi A, Drahos J, Ricker W, Parsons R, et al. Endoscopic ultrasonography in esophageal cancer leads to improved survival rates: Results from a population-based study. Cancer 2015;121:194–201.
   PubMed Web of Science ®Google Scholar
• Li J, Shen Y, Tan L, Feng M, Wang H, Xi Y, et al. Is minimally invasive esophagectomy beneficial to elderly patients with esophageal cancer? Surg Endosc 2015;29:925–30.
   PubMed Web of Science ®Google Scholar
• Manzano JG, Luo R, Elting LS, George M, Saurez-Almazor ME. Patterns and Predictors of Unplanned Hospitalization in a Population-Based Cohort of Elderly Patients With GI Cancer. J Clin Oncol 2014;32:3527–33.
   PubMed Web of Science ®Google Scholar
• Wagner AD, Unverzagt S, Grothe W, et al. Chemotherapy for advanced gastric cancer. Cochrane Database Syst Rev. 2010 Mar 17;(3):CD004064. doi: 10.1002/14651858.CD004064.pub3.
   Google Scholar
• Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJH, Nicolson M, et al. Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer. N Engl J Med 2006;355:11–20.
   PubMed Web of Science ®Google Scholar
• Ychou M, Boige V, Pignon JP, Conroy T, Bouche O, Lebreton G, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol 2011;29:1715–21.
   PubMed Web of Science ®Google Scholar
• Larsen AC, Holländer C, Duval L, Achiam M, Pfeiffer P, Yilmaz MK, et al. A Nationwide retrospective study of perioperative chemotherapy for gastroesophageal adenocarcinoma: tolerability, outcome, and prognostic factors. Ann Surg Oncol 2015;22:1540–47.
   PubMed Web of Science ®Google Scholar